| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 33 | 2024 | 3497 | 3.650 |
Why?
|
| Neuroblastoma | 13 | 2023 | 1225 | 3.180 |
Why?
|
| RNA-Binding Protein EWS | 12 | 2023 | 216 | 2.400 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 10 | 2023 | 102 | 2.390 |
Why?
|
| Xenograft Model Antitumor Assays | 24 | 2021 | 3557 | 2.070 |
Why?
|
| Oncogene Proteins, Fusion | 17 | 2023 | 1581 | 1.980 |
Why?
|
| Gene Expression Regulation, Neoplastic | 27 | 2023 | 8425 | 1.810 |
Why?
|
| Leukemia | 9 | 2021 | 1507 | 1.740 |
Why?
|
| Cell Line, Tumor | 58 | 2023 | 16665 | 1.730 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 10 | 2023 | 407 | 1.710 |
Why?
|
| Cyclin-Dependent Kinase 4 | 5 | 2019 | 535 | 1.530 |
Why?
|
| Receptor, Notch1 | 7 | 2020 | 502 | 1.520 |
Why?
|
| Bone Neoplasms | 9 | 2022 | 2522 | 1.510 |
Why?
|
| Protein Kinase Inhibitors | 23 | 2023 | 5522 | 1.310 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 6 | 2020 | 491 | 1.260 |
Why?
|
| Drug Resistance, Neoplasm | 12 | 2021 | 5163 | 1.200 |
Why?
|
| Antineoplastic Agents | 25 | 2021 | 13655 | 1.140 |
Why?
|
| Gene Expression Regulation, Leukemic | 8 | 2019 | 651 | 1.070 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2020 | 2455 | 1.050 |
Why?
|
| Glycine Hydroxymethyltransferase | 2 | 2022 | 32 | 1.010 |
Why?
|
| Molecular Targeted Therapy | 13 | 2022 | 2723 | 0.970 |
Why?
|
| Glycogen Synthase Kinase 3 | 6 | 2022 | 430 | 0.910 |
Why?
|
| Gene Amplification | 7 | 2021 | 1062 | 0.890 |
Why?
|
| Sulfonamides | 3 | 2024 | 1932 | 0.840 |
Why?
|
| Creatine Kinase | 3 | 2023 | 694 | 0.830 |
Why?
|
| Azepines | 4 | 2019 | 336 | 0.830 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 5 | 2017 | 345 | 0.810 |
Why?
|
| Cell Cycle Proteins | 10 | 2023 | 3444 | 0.790 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2022 | 2906 | 0.790 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2021 | 76 | 0.770 |
Why?
|
| Genome, Human | 6 | 2021 | 4420 | 0.760 |
Why?
|
| Enzyme Inhibitors | 8 | 2023 | 3800 | 0.760 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 647 | 0.750 |
Why?
|
| Indazoles | 2 | 2019 | 287 | 0.750 |
Why?
|
| Transcription Factors | 18 | 2023 | 12164 | 0.710 |
Why?
|
| Cell Survival | 15 | 2022 | 5872 | 0.710 |
Why?
|
| Folic Acid | 3 | 2021 | 1300 | 0.700 |
Why?
|
| Cell Proliferation | 23 | 2021 | 10472 | 0.700 |
Why?
|
| Cyclin-Dependent Kinase 6 | 3 | 2019 | 322 | 0.700 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 | 2023 | 1515 | 0.690 |
Why?
|
| Mice, Inbred NOD | 11 | 2021 | 1875 | 0.680 |
Why?
|
| Triazoles | 5 | 2019 | 907 | 0.670 |
Why?
|
| Drug Synergism | 7 | 2019 | 1791 | 0.670 |
Why?
|
| Cell Differentiation | 13 | 2023 | 11470 | 0.670 |
Why?
|
| Aminopyridines | 4 | 2019 | 541 | 0.660 |
Why?
|
| Mutation | 23 | 2023 | 29717 | 0.630 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2021 | 670 | 0.630 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2018 | 2107 | 0.630 |
Why?
|
| Drug Discovery | 4 | 2022 | 1057 | 0.630 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2020 | 987 | 0.620 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2023 | 2948 | 0.620 |
Why?
|
| Lymphoma, T-Cell | 1 | 2020 | 299 | 0.610 |
Why?
|
| Genomics | 10 | 2016 | 5692 | 0.600 |
Why?
|
| Phenylenediamines | 1 | 2018 | 90 | 0.600 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2013 | 789 | 0.590 |
Why?
|
| High-Throughput Screening Assays | 5 | 2019 | 944 | 0.580 |
Why?
|
| Gene Expression Profiling | 14 | 2021 | 9410 | 0.580 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 449 | 0.580 |
Why?
|
| Small Molecule Libraries | 7 | 2020 | 721 | 0.580 |
Why?
|
| Methenyltetrahydrofolate Cyclohydrolase | 1 | 2016 | 9 | 0.580 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2023 | 9185 | 0.560 |
Why?
|
| Proto-Oncogenes | 2 | 2017 | 321 | 0.560 |
Why?
|
| Neoplasms | 16 | 2021 | 21596 | 0.560 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2018 | 390 | 0.550 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2024 | 2940 | 0.540 |
Why?
|
| Oncogene Proteins | 4 | 2014 | 749 | 0.530 |
Why?
|
| Mice | 46 | 2023 | 81045 | 0.520 |
Why?
|
| Citric Acid Cycle | 1 | 2016 | 231 | 0.510 |
Why?
|
| Neoplasm Proteins | 7 | 2021 | 3691 | 0.500 |
Why?
|
| Methotrexate | 1 | 2021 | 1720 | 0.500 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 1213 | 0.490 |
Why?
|
| Pyrimidines | 5 | 2021 | 2933 | 0.480 |
Why?
|
| Animals | 60 | 2023 | 168561 | 0.480 |
Why?
|
| Mice, Nude | 8 | 2019 | 3689 | 0.480 |
Why?
|
| Casein Kinase I | 1 | 2014 | 47 | 0.480 |
Why?
|
| Nuclear Proteins | 9 | 2023 | 5851 | 0.480 |
Why?
|
| Humans | 138 | 2024 | 742088 | 0.470 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 192 | 0.470 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2019 | 234 | 0.470 |
Why?
|
| Signal Transduction | 22 | 2024 | 23387 | 0.470 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2021 | 640 | 0.470 |
Why?
|
| Cyclin D1 | 1 | 2015 | 462 | 0.460 |
Why?
|
| U937 Cells | 7 | 2020 | 268 | 0.460 |
Why?
|
| HL-60 Cells | 7 | 2016 | 365 | 0.450 |
Why?
|
| Purines | 1 | 2016 | 593 | 0.450 |
Why?
|
| Histone Deacetylase 2 | 1 | 2013 | 74 | 0.450 |
Why?
|
| Apoptosis | 16 | 2024 | 9715 | 0.440 |
Why?
|
| Chromosome Mapping | 2 | 2021 | 4742 | 0.440 |
Why?
|
| Transcription, Genetic | 6 | 2019 | 7721 | 0.440 |
Why?
|
| Drug Screening Assays, Antitumor | 5 | 2020 | 731 | 0.430 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 182 | 0.430 |
Why?
|
| Lactams | 1 | 2013 | 155 | 0.430 |
Why?
|
| Histone Deacetylase 1 | 1 | 2013 | 137 | 0.430 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2013 | 127 | 0.430 |
Why?
|
| Proteomics | 6 | 2022 | 3618 | 0.420 |
Why?
|
| Mice, SCID | 6 | 2021 | 2715 | 0.410 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 9 | 2023 | 11472 | 0.410 |
Why?
|
| DNA-Binding Proteins | 8 | 2021 | 9639 | 0.360 |
Why?
|
| Up-Regulation | 3 | 2017 | 4211 | 0.350 |
Why?
|
| Tumor Cells, Cultured | 8 | 2021 | 6313 | 0.350 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 129 | 0.330 |
Why?
|
| RNA Interference | 8 | 2018 | 2890 | 0.330 |
Why?
|
| Cytarabine | 2 | 2009 | 684 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 4465 | 0.320 |
Why?
|
| Quinazolines | 4 | 2019 | 1355 | 0.320 |
Why?
|
| Proteins | 5 | 2021 | 6096 | 0.310 |
Why?
|
| Retinoids | 1 | 2008 | 96 | 0.310 |
Why?
|
| Carrier Proteins | 1 | 2021 | 5019 | 0.310 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 2217 | 0.310 |
Why?
|
| RNA, Small Interfering | 8 | 2018 | 3504 | 0.310 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2018 | 3585 | 0.300 |
Why?
|
| HEK293 Cells | 8 | 2021 | 4200 | 0.300 |
Why?
|
| Rhabdoid Tumor | 2 | 2019 | 212 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-ets | 6 | 2023 | 318 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 12 | 5 | 1997 | 462 | 0.290 |
Why?
|
| Galectin 3 | 1 | 2008 | 227 | 0.280 |
Why?
|
| Cell Cycle | 5 | 2023 | 2964 | 0.280 |
Why?
|
| Epigenesis, Genetic | 5 | 2021 | 3639 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2024 | 1434 | 0.270 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2009 | 3920 | 0.270 |
Why?
|
| Down-Regulation | 5 | 2018 | 3001 | 0.270 |
Why?
|
| Thapsigargin | 2 | 2017 | 104 | 0.270 |
Why?
|
| Phosphorylation | 8 | 2019 | 8436 | 0.260 |
Why?
|
| Cell Death | 3 | 2019 | 1695 | 0.250 |
Why?
|
| Gene Expression | 9 | 2022 | 7790 | 0.250 |
Why?
|
| Protein Stability | 3 | 2021 | 556 | 0.250 |
Why?
|
| Child | 25 | 2024 | 77478 | 0.250 |
Why?
|
| Gene Knockdown Techniques | 4 | 2022 | 1655 | 0.250 |
Why?
|
| Leukemia, Myeloid | 3 | 2015 | 705 | 0.240 |
Why?
|
| Neoplasm Transplantation | 4 | 2016 | 2085 | 0.240 |
Why?
|
| Flow Cytometry | 6 | 2017 | 5975 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2023 | 1097 | 0.230 |
Why?
|
| Ubiquitination | 3 | 2024 | 1011 | 0.230 |
Why?
|
| Gene Knockout Techniques | 3 | 2021 | 808 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2023 | 52 | 0.220 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2024 | 195 | 0.220 |
Why?
|
| Translocation, Genetic | 6 | 2018 | 1417 | 0.220 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1372 | 0.220 |
Why?
|
| Blotting, Western | 3 | 2017 | 5180 | 0.220 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2023 | 167 | 0.210 |
Why?
|
| Vaccinia | 1 | 2022 | 76 | 0.210 |
Why?
|
| Gene Dosage | 2 | 2017 | 1251 | 0.210 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2024 | 169 | 0.210 |
Why?
|
| Cystine | 1 | 2022 | 95 | 0.210 |
Why?
|
| Protein Kinases | 2 | 2020 | 1638 | 0.200 |
Why?
|
| Gangliosides | 1 | 2022 | 140 | 0.200 |
Why?
|
| Chromatin | 5 | 2023 | 2917 | 0.200 |
Why?
|
| Immunologic Memory | 1 | 2008 | 1348 | 0.200 |
Why?
|
| POU Domain Factors | 1 | 2021 | 46 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 4751 | 0.200 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 2 | 2022 | 282 | 0.200 |
Why?
|
| Cell Lineage | 4 | 2019 | 2504 | 0.190 |
Why?
|
| Creatine | 1 | 2023 | 421 | 0.190 |
Why?
|
| Asparaginase | 2 | 2019 | 235 | 0.190 |
Why?
|
| Pharmaceutical Preparations | 1 | 2009 | 1071 | 0.190 |
Why?
|
| CDC2 Protein Kinase | 1 | 2021 | 220 | 0.180 |
Why?
|
| Diphenylamine | 1 | 2019 | 50 | 0.180 |
Why?
|
| Morpholines | 2 | 2016 | 561 | 0.180 |
Why?
|
| Female | 31 | 2021 | 379592 | 0.180 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 144 | 0.180 |
Why?
|
| Homeodomain Proteins | 2 | 2021 | 2417 | 0.180 |
Why?
|
| Trisomy | 1 | 2021 | 266 | 0.180 |
Why?
|
| Burkitt Lymphoma | 1 | 2022 | 328 | 0.170 |
Why?
|
| Dipeptides | 2 | 2018 | 409 | 0.170 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2020 | 195 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2019 | 1723 | 0.170 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2020 | 284 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2019 | 380 | 0.170 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 290 | 0.170 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2018 | 40 | 0.170 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2019 | 120 | 0.170 |
Why?
|
| Hematologic Neoplasms | 1 | 2011 | 1820 | 0.170 |
Why?
|
| T-Lymphocytes | 7 | 2023 | 10163 | 0.170 |
Why?
|
| Thiophenes | 2 | 2018 | 590 | 0.160 |
Why?
|
| Bepridil | 1 | 2018 | 12 | 0.160 |
Why?
|
| Transfection | 4 | 2015 | 5892 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2022 | 1114 | 0.160 |
Why?
|
| Folate Receptor 2 | 1 | 2017 | 5 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 341 | 0.160 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 319 | 0.160 |
Why?
|
| Gene Fusion | 1 | 2021 | 371 | 0.160 |
Why?
|
| Zebrafish | 5 | 2021 | 2990 | 0.160 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 794 | 0.160 |
Why?
|
| Anilides | 1 | 2021 | 404 | 0.160 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2020 | 337 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2018 | 2938 | 0.160 |
Why?
|
| Repressor Proteins | 6 | 2018 | 3020 | 0.160 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2022 | 670 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 489 | 0.160 |
Why?
|
| HMGB Proteins | 1 | 2017 | 45 | 0.160 |
Why?
|
| Gene Duplication | 2 | 2021 | 330 | 0.150 |
Why?
|
| DNA Damage | 3 | 2023 | 2423 | 0.150 |
Why?
|
| Models, Genetic | 3 | 2017 | 3493 | 0.150 |
Why?
|
| Glioma | 2 | 2022 | 3388 | 0.150 |
Why?
|
| Acute Disease | 4 | 2018 | 7141 | 0.150 |
Why?
|
| I-kappa B Kinase | 1 | 2018 | 251 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 5867 | 0.150 |
Why?
|
| Molecular Structure | 4 | 2021 | 1907 | 0.150 |
Why?
|
| Peptide Hydrolases | 1 | 2020 | 627 | 0.150 |
Why?
|
| Benzamides | 2 | 2019 | 1378 | 0.150 |
Why?
|
| Bone Marrow | 2 | 2019 | 2941 | 0.150 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2019 | 627 | 0.150 |
Why?
|
| Integrin beta3 | 2 | 2017 | 122 | 0.150 |
Why?
|
| Tretinoin | 2 | 2013 | 516 | 0.140 |
Why?
|
| Pyridines | 4 | 2020 | 2818 | 0.140 |
Why?
|
| Benzothiazoles | 1 | 2017 | 247 | 0.140 |
Why?
|
| Oncogenes | 3 | 2022 | 1263 | 0.140 |
Why?
|
| Histones | 4 | 2023 | 2597 | 0.140 |
Why?
|
| Polyethylene Glycols | 2 | 2019 | 1181 | 0.140 |
Why?
|
| Open Reading Frames | 1 | 2019 | 810 | 0.140 |
Why?
|
| Protease Inhibitors | 1 | 2020 | 790 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 730 | 0.140 |
Why?
|
| Peptides, Cyclic | 1 | 2018 | 401 | 0.140 |
Why?
|
| Microfilament Proteins | 1 | 2021 | 1152 | 0.130 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2015 | 20 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2021 | 10943 | 0.130 |
Why?
|
| Clone Cells | 1 | 2019 | 1692 | 0.130 |
Why?
|
| Karyopherins | 1 | 2016 | 132 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 4379 | 0.130 |
Why?
|
| Tissue Banks | 1 | 2016 | 183 | 0.130 |
Why?
|
| Pyrimidinones | 1 | 2017 | 370 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 2 | 1996 | 2842 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 2502 | 0.130 |
Why?
|
| Aniline Compounds | 1 | 2020 | 983 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 4 | 2020 | 6382 | 0.130 |
Why?
|
| Calcium Channel Blockers | 1 | 2018 | 689 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 1337 | 0.120 |
Why?
|
| Wnt Proteins | 1 | 2018 | 721 | 0.120 |
Why?
|
| HMGN1 Protein | 1 | 2014 | 27 | 0.120 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 914 | 0.120 |
Why?
|
| DNA Copy Number Variations | 3 | 2017 | 1940 | 0.120 |
Why?
|
| Genetic Heterogeneity | 2 | 2019 | 732 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2014 | 13029 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 585 | 0.120 |
Why?
|
| Gene Rearrangement | 2 | 2022 | 1179 | 0.120 |
Why?
|
| Triazines | 1 | 2016 | 316 | 0.120 |
Why?
|
| Niacinamide | 1 | 2016 | 416 | 0.120 |
Why?
|
| Medulloblastoma | 1 | 2019 | 681 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 2 | 1996 | 1086 | 0.120 |
Why?
|
| Pyrazines | 1 | 2019 | 1231 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2022 | 2500 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2021 | 1402 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2017 | 695 | 0.110 |
Why?
|
| Endocytosis | 1 | 2017 | 983 | 0.110 |
Why?
|
| DNA, Neoplasm | 3 | 2014 | 1758 | 0.110 |
Why?
|
| Acetylation | 2 | 2022 | 1085 | 0.110 |
Why?
|
| Biological Transport | 1 | 2017 | 2119 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 526 | 0.110 |
Why?
|
| Osteosarcoma | 1 | 2018 | 880 | 0.110 |
Why?
|
| Gene Targeting | 1 | 2016 | 880 | 0.110 |
Why?
|
| Neurogenesis | 1 | 2019 | 829 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1525 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 782 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1659 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 552 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 17400 | 0.110 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 400 | 0.100 |
Why?
|
| Carcinoma | 1 | 2023 | 2374 | 0.100 |
Why?
|
| Ribonucleoproteins | 1 | 2014 | 381 | 0.100 |
Why?
|
| Mitochondria | 3 | 2023 | 3520 | 0.100 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 768 | 0.100 |
Why?
|
| Technology, Pharmaceutical | 1 | 2012 | 85 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 867 | 0.100 |
Why?
|
| Piperidines | 1 | 2020 | 1602 | 0.100 |
Why?
|
| Protein Binding | 3 | 2018 | 9387 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2009 | 459 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2019 | 4553 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2021 | 2924 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2016 | 554 | 0.100 |
Why?
|
| Protein Isoforms | 3 | 2023 | 1727 | 0.100 |
Why?
|
| Proteome | 2 | 2018 | 1790 | 0.100 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 1145 | 0.100 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 19862 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5062 | 0.100 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 6891 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 1799 | 0.090 |
Why?
|
| Interferon Regulatory Factors | 2 | 2022 | 270 | 0.090 |
Why?
|
| Point Mutation | 1 | 1996 | 1624 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 625 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 21821 | 0.090 |
Why?
|
| Lentivirus | 1 | 2013 | 501 | 0.090 |
Why?
|
| Gene Library | 1 | 2013 | 1076 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 584 | 0.090 |
Why?
|
| Exons | 1 | 1996 | 2431 | 0.090 |
Why?
|
| Gene Deletion | 3 | 1997 | 2751 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2015 | 1905 | 0.090 |
Why?
|
| Lysine | 1 | 2014 | 1008 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2016 | 1949 | 0.090 |
Why?
|
| Male | 21 | 2021 | 349538 | 0.090 |
Why?
|
| Adult | 11 | 2024 | 213712 | 0.090 |
Why?
|
| Calcium Channels | 1 | 2013 | 621 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 18006 | 0.080 |
Why?
|
| Fluorouracil | 1 | 2014 | 1615 | 0.080 |
Why?
|
| Mucin-1 | 1 | 2013 | 543 | 0.080 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2019 | 1351 | 0.080 |
Why?
|
| Prognosis | 6 | 2021 | 29010 | 0.080 |
Why?
|
| Cell Movement | 1 | 2021 | 5212 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2021 | 11363 | 0.080 |
Why?
|
| Immunomagnetic Separation | 1 | 2008 | 80 | 0.080 |
Why?
|
| Metabolomics | 1 | 2017 | 1467 | 0.080 |
Why?
|
| Structure-Activity Relationship | 3 | 2021 | 3133 | 0.080 |
Why?
|
| Receptors, CCR7 | 1 | 2008 | 108 | 0.080 |
Why?
|
| Oxazines | 1 | 2009 | 298 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 1284 | 0.080 |
Why?
|
| Cysteine | 2 | 2023 | 873 | 0.080 |
Why?
|
| Fluorometry | 1 | 2007 | 106 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 4801 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2017 | 12220 | 0.070 |
Why?
|
| Lymphoma | 1 | 2016 | 1873 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 2014 | 230 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1596 | 0.070 |
Why?
|
| Disease Progression | 2 | 2021 | 13256 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2008 | 323 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3847 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2009 | 1683 | 0.070 |
Why?
|
| Biology | 1 | 2007 | 292 | 0.070 |
Why?
|
| Drosophila | 1 | 2013 | 1484 | 0.070 |
Why?
|
| Computational Biology | 1 | 2017 | 3518 | 0.060 |
Why?
|
| Tyrosine | 1 | 2009 | 1460 | 0.060 |
Why?
|
| Binding Sites | 3 | 2023 | 6115 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 1996 | 322 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2005 | 232 | 0.060 |
Why?
|
| Sarcoma | 1 | 2016 | 1895 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 2382 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2007 | 766 | 0.060 |
Why?
|
| Molecular Weight | 1 | 2007 | 2255 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2018 | 2712 | 0.060 |
Why?
|
| Microspheres | 1 | 2007 | 777 | 0.060 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 729 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2009 | 804 | 0.060 |
Why?
|
| Survival Rate | 2 | 2020 | 12773 | 0.060 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2005 | 233 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2006 | 434 | 0.060 |
Why?
|
| Cell Culture Techniques | 2 | 2008 | 1670 | 0.060 |
Why?
|
| STAT Transcription Factors | 1 | 2024 | 182 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 1157 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2017 | 6191 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7901 | 0.060 |
Why?
|
| Janus Kinases | 1 | 2024 | 244 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2021 | 19223 | 0.050 |
Why?
|
| Time Factors | 3 | 2015 | 40054 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2011 | 4013 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 4029 | 0.050 |
Why?
|
| Inflammation | 1 | 2022 | 10578 | 0.050 |
Why?
|
| Formates | 1 | 2022 | 43 | 0.050 |
Why?
|
| Daunorubicin | 1 | 2022 | 149 | 0.050 |
Why?
|
| Sulfasalazine | 1 | 2022 | 79 | 0.050 |
Why?
|
| Protein Array Analysis | 1 | 2004 | 411 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2023 | 309 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2023 | 430 | 0.050 |
Why?
|
| Alleles | 1 | 2013 | 6931 | 0.050 |
Why?
|
| Base Sequence | 4 | 2013 | 12797 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 379 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2022 | 131 | 0.050 |
Why?
|
| Pattern Recognition, Automated | 1 | 2007 | 996 | 0.050 |
Why?
|
| Microsomes, Liver | 1 | 2021 | 175 | 0.050 |
Why?
|
| Medical Oncology | 3 | 2020 | 2235 | 0.050 |
Why?
|
| Histocompatibility Antigens | 1 | 2022 | 471 | 0.050 |
Why?
|
| Ikaros Transcription Factor | 1 | 2022 | 214 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3731 | 0.050 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2020 | 38 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2004 | 435 | 0.050 |
Why?
|
| Nucleotides | 1 | 2023 | 463 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 40450 | 0.050 |
Why?
|
| Vaccinia virus | 1 | 2022 | 349 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4664 | 0.050 |
Why?
|
| Doxorubicin | 2 | 2018 | 2215 | 0.050 |
Why?
|
| beta Catenin | 2 | 2018 | 1058 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2006 | 1057 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2024 | 874 | 0.040 |
Why?
|
| Histone Demethylases | 1 | 2022 | 320 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 352 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2020 | 194 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 9274 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 101 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2021 | 462 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 53187 | 0.040 |
Why?
|
| Nervous System | 1 | 2022 | 553 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2020 | 14554 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 1915 | 0.040 |
Why?
|
| Smad2 Protein | 1 | 2019 | 156 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 18112 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2014 | 433 | 0.040 |
Why?
|
| Glycine | 1 | 2022 | 671 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2020 | 249 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2015 | 3701 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2019 | 321 | 0.040 |
Why?
|
| Indoles | 2 | 2019 | 1834 | 0.040 |
Why?
|
| Neurons | 1 | 2017 | 9325 | 0.040 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 2 | 1997 | 97 | 0.040 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 113 | 0.040 |
Why?
|
| S Phase | 1 | 2019 | 423 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2022 | 1470 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 298 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 742 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 2 | 2016 | 2011 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2022 | 861 | 0.040 |
Why?
|
| Karyotyping | 1 | 2019 | 1243 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 1135 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 836 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 995 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2017 | 5454 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 13019 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2022 | 1608 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2017 | 408 | 0.030 |
Why?
|
| DNA Cleavage | 1 | 2016 | 58 | 0.030 |
Why?
|
| United States | 2 | 2021 | 69693 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2015 | 118 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 335 | 0.030 |
Why?
|
| Vincristine | 1 | 2018 | 1036 | 0.030 |
Why?
|
| Leukemia, Experimental | 1 | 2016 | 246 | 0.030 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1995 | 118 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 427 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2018 | 891 | 0.030 |
Why?
|
| Piperazines | 2 | 2016 | 2488 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2019 | 894 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 6534 | 0.030 |
Why?
|
| Bone Marrow Examination | 1 | 2015 | 157 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2014 | 15 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 2077 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 628 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2018 | 40955 | 0.030 |
Why?
|
| Genes, Essential | 1 | 2016 | 182 | 0.030 |
Why?
|
| Epigenomics | 1 | 2020 | 902 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2018 | 607 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2014 | 70 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 1274 | 0.030 |
Why?
|
| Hydrazines | 1 | 2016 | 220 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2022 | 4282 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 1376 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 368 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 57683 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 1400 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 563 | 0.030 |
Why?
|
| Cell Line | 3 | 2019 | 15994 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 222 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1118 | 0.030 |
Why?
|
| DNA Replication | 1 | 2021 | 1397 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2022 | 4771 | 0.030 |
Why?
|
| Solubility | 1 | 2015 | 1083 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2019 | 3381 | 0.030 |
Why?
|
| Models, Animal | 1 | 2020 | 2170 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3339 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 130 | 0.030 |
Why?
|
| DNA Replication Timing | 1 | 2013 | 35 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2016 | 755 | 0.030 |
Why?
|
| Software | 1 | 2007 | 4434 | 0.030 |
Why?
|
| Prednisone | 1 | 2018 | 1567 | 0.030 |
Why?
|
| Adolescent | 6 | 2023 | 85649 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1683 | 0.030 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2013 | 96 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 20774 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 14720 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 1333 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1581 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 783 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 1546 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 2024 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 1811 | 0.030 |
Why?
|
| Remission Induction | 1 | 2018 | 2384 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 847 | 0.030 |
Why?
|
| Aneuploidy | 1 | 1995 | 530 | 0.030 |
Why?
|
| Consensus | 1 | 2021 | 2935 | 0.030 |
Why?
|
| DNA Repair | 1 | 2021 | 2042 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2023 | 2896 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2425 | 0.020 |
Why?
|
| Infant | 4 | 2018 | 35070 | 0.020 |
Why?
|
| Methylation | 1 | 2014 | 1107 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 2006 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 892 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2015 | 1725 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 1995 | 1526 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 981 | 0.020 |
Why?
|
| Drug Design | 1 | 2016 | 1078 | 0.020 |
Why?
|
| Recurrence | 1 | 2022 | 8333 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2014 | 493 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2013 | 62966 | 0.020 |
Why?
|
| Sample Size | 1 | 2013 | 844 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2066 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 2915 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1995 | 2638 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1995 | 2633 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6483 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2010 | 1159 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2018 | 10248 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2010 | 1101 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1119 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2010 | 1094 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 1728 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2615 | 0.020 |
Why?
|
| Phenotype | 2 | 2016 | 16331 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1625 | 0.020 |
Why?
|
| Metribolone | 1 | 2006 | 13 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1996 | 4187 | 0.020 |
Why?
|
| Aged | 2 | 2017 | 162944 | 0.020 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2006 | 36 | 0.020 |
Why?
|
| Limonins | 1 | 2006 | 24 | 0.020 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 1997 | 96 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2022 | 4414 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3862 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9735 | 0.020 |
Why?
|
| Triterpenes | 1 | 2006 | 79 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 1997 | 180 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2006 | 201 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 2763 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 3564 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4839 | 0.020 |
Why?
|
| Middle Aged | 2 | 2017 | 213127 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2006 | 319 | 0.020 |
Why?
|
| Artifacts | 1 | 2013 | 1903 | 0.020 |
Why?
|
| Young Adult | 2 | 2023 | 56350 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2006 | 1374 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2014 | 1970 | 0.010 |
Why?
|
| Pediatrics | 1 | 2019 | 3462 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3062 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3293 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 692 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1675 | 0.010 |
Why?
|
| Peptides | 1 | 2013 | 4392 | 0.010 |
Why?
|
| DNA Primers | 1 | 2006 | 2892 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1997 | 4322 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2007 | 1780 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 5979 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15056 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 9941 | 0.010 |
Why?
|
| Algorithms | 1 | 2017 | 13853 | 0.010 |
Why?
|
| Genes, abl | 1 | 1997 | 72 | 0.010 |
Why?
|
| Life Tables | 1 | 1996 | 370 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1997 | 188 | 0.010 |
Why?
|
| Dimerization | 1 | 1996 | 893 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1996 | 403 | 0.010 |
Why?
|
| Prostatic Neoplasms | 2 | 2007 | 11039 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1996 | 537 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2010 | 7873 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 2837 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 2257 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 77098 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 72145 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6171 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 13814 | 0.000 |
Why?
|